Statistics
Total Visits
| Views | |
|---|---|
| Use of lanreotide in combination with cabergoline or pegvisomant in patients with acromegaly in the clinical practice: the ACROCOMB study | 287 |
Total Visits Per Month
| November 2023 | December 2023 | January 2024 | February 2024 | March 2024 | April 2024 | May 2024 | June 2024 | July 2024 | August 2024 | September 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Use of lanreotide in combination with cabergoline or pegvisomant in patients with acromegaly in the clinical practice: the ACROCOMB study | 1 | 8 | 6 | 0 | 1 | 2 | 4 | 9 | 13 | 4 | 6 |
File Visits
| Views | |
|---|---|
| PuigDmngo_UseLnrtde.pdf | 521 |
Top country views
| Views | |
|---|---|
| United States | 206 |
| Sweden | 22 |
| Germany | 10 |
| China | 7 |
| Australia | 5 |
| Ukraine | 4 |
| Argentina | 3 |
| Spain | 3 |
| Ireland | 3 |
| Japan | 3 |
Top cities views
| Views | |
|---|---|
| Ashburn | 77 |
| Fairfield | 44 |
| Cambridge | 21 |
| Louisville | 11 |
| Mountain View | 7 |
| Stockholm | 7 |
| Dearborn | 6 |
| Seattle | 6 |
| Jacksonville | 5 |
| San Diego | 3 |
